Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-24-126726
Filing Date
2024-11-14
Accepted
2024-11-14 07:00:09
Documents
30
Period of Report
2024-11-14

Document Format Files

Seq Description Document Type Size
1 6-K i_-_mab_6k_q3_2024.htm 6-K 25816
2 EX-99.1 imab-ex99_1.htm EX-99.1 327805
3 EX-99.2 imab-ex99_2.htm EX-99.2 39947
4 GRAPHIC imab-ex99_2s1.jpg GRAPHIC 191790
5 GRAPHIC imab-ex99_2s2.jpg GRAPHIC 887835
6 GRAPHIC imab-ex99_2s3.jpg GRAPHIC 245643
7 GRAPHIC imab-ex99_2s4.jpg GRAPHIC 388211
8 GRAPHIC imab-ex99_2s5.jpg GRAPHIC 276768
9 GRAPHIC imab-ex99_2s6.jpg GRAPHIC 350443
10 GRAPHIC imab-ex99_2s7.jpg GRAPHIC 423474
11 GRAPHIC imab-ex99_2s8.jpg GRAPHIC 329527
12 GRAPHIC imab-ex99_2s9.jpg GRAPHIC 332723
13 GRAPHIC imab-ex99_2s10.jpg GRAPHIC 385640
14 GRAPHIC imab-ex99_2s11.jpg GRAPHIC 250824
15 GRAPHIC imab-ex99_2s12.jpg GRAPHIC 333704
16 GRAPHIC imab-ex99_2s13.jpg GRAPHIC 342801
17 GRAPHIC imab-ex99_2s14.jpg GRAPHIC 345375
18 GRAPHIC imab-ex99_2s15.jpg GRAPHIC 317883
19 GRAPHIC imab-ex99_2s16.jpg GRAPHIC 478375
20 GRAPHIC imab-ex99_2s17.jpg GRAPHIC 452523
21 GRAPHIC imab-ex99_2s18.jpg GRAPHIC 410622
22 GRAPHIC imab-ex99_2s19.jpg GRAPHIC 428588
23 GRAPHIC imab-ex99_2s20.jpg GRAPHIC 338497
24 GRAPHIC imab-ex99_2s21.jpg GRAPHIC 489108
25 GRAPHIC imab-ex99_2s22.jpg GRAPHIC 336587
26 GRAPHIC imab-ex99_2s23.jpg GRAPHIC 421703
27 GRAPHIC imab-ex99_2s24.jpg GRAPHIC 385212
28 GRAPHIC imab-ex99_2s25.jpg GRAPHIC 356794
29 GRAPHIC imab-ex99_2s26.jpg GRAPHIC 386067
30 GRAPHIC imab-ex99_2s27.jpg GRAPHIC 212517
  Complete submission text file 0000950170-24-126726.txt   14300140
Mailing Address SUITE 400, 2440 RESEARCH BLVD ROCKVILLE MD 20850
Business Address SUITE 400, 2440 RESEARCH BLVD ROCKVILLE MD 20850 (301) 670 2800
I-Mab (Filer) CIK: 0001778016 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39173 | Film No.: 241457050
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)